Food and Drug Administration
August 27, 2004
Briefing Information
Pegaptanib Sodium Injection in the Treatment of Neovascular Age-Related Macular Degeneration, Eyetech Pharmaceuticals, Inc. and Pfizer, Inc. (PDF)
Macugen (Pegaptanib Sodium Injection) for the Treatment of Neovascular Age-Related Macular Degeneration, FDA (HTM) (PDF) (Word)
FDA Background Errata - Corrections for Macugen Briefing Document (NDA 21-856) (HTM) (PDF) (Word)